Thank you!

Your email has been successfully added to our mailing list.

×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
No thanks

LXEO – lexeo therapeutics, inc. (US:NASDAQ)

DELAYED
$
Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low
VWAP
Today’s Volatility
20 Day Volatility
Open
Prior Close
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
LXEO
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
11/28
06:04 am
lxeo
Form EFFECT Lexeo Therapeutics, Inc.
Low Report
Form EFFECT Lexeo Therapeutics, Inc.
Report
11/26
04:30 pm
lxeo
Form 424B3 Lexeo Therapeutics, Inc.
Medium Report
Form 424B3 Lexeo Therapeutics, Inc.
Report
11/20
05:21 pm
lxeo
Form 4 Lexeo Therapeutics, Inc. For: Nov 18 Filed by: Townsend Richard Nolan
Low Report
Form 4 Lexeo Therapeutics, Inc. For: Nov 18 Filed by: Townsend Richard Nolan
Report
11/20
05:20 pm
lxeo
Form 4 Lexeo Therapeutics, Inc. For: Nov 18 Filed by: Adler Eric
Low Report
Form 4 Lexeo Therapeutics, Inc. For: Nov 18 Filed by: Adler Eric
Report
11/20
05:19 pm
lxeo
Form 4 Lexeo Therapeutics, Inc. For: Nov 18 Filed by: See Tai Sandi
Low Report
Form 4 Lexeo Therapeutics, Inc. For: Nov 18 Filed by: See Tai Sandi
Report
11/20
05:18 pm
lxeo
Form 4 Lexeo Therapeutics, Inc. For: Nov 18 Filed by: Robertson Jenny
Low Report
Form 4 Lexeo Therapeutics, Inc. For: Nov 18 Filed by: Robertson Jenny
Report
11/20
05:15 pm
lxeo
Form 4 Lexeo Therapeutics, Inc. For: Nov 18 Filed by: Otero Jose Manuel
Low Report
Form 4 Lexeo Therapeutics, Inc. For: Nov 18 Filed by: Otero Jose Manuel
Report
11/20
04:30 pm
lxeo
Form SCHEDULE 13G Lexeo Therapeutics, Inc. Filed by: Paradigm Biocapital Advisors LP
Low Report
Form SCHEDULE 13G Lexeo Therapeutics, Inc. Filed by: Paradigm Biocapital Advisors LP
Report
11/18
03:46 pm
lxeo
Form 144 Lexeo Therapeutics, Inc. Filed by: Robertson Jenny
Low Report
Form 144 Lexeo Therapeutics, Inc. Filed by: Robertson Jenny
Report
11/18
03:39 pm
lxeo
Form 144 Lexeo Therapeutics, Inc. Filed by: See Tai Sandi
Low Report
Form 144 Lexeo Therapeutics, Inc. Filed by: See Tai Sandi
Report
11/18
03:38 pm
lxeo
Form 144 Lexeo Therapeutics, Inc. Filed by: Otero Jose Manuel
Low Report
Form 144 Lexeo Therapeutics, Inc. Filed by: Otero Jose Manuel
Report
11/18
03:31 pm
lxeo
Form 144 Lexeo Therapeutics, Inc. Filed by: Adler Eric
Low Report
Form 144 Lexeo Therapeutics, Inc. Filed by: Adler Eric
Report
11/18
03:13 pm
lxeo
Form 144 Lexeo Therapeutics, Inc. Filed by: Townsend Richard Nolan
Low Report
Form 144 Lexeo Therapeutics, Inc. Filed by: Townsend Richard Nolan
Report
11/14
04:24 pm
lxeo
Form SCHEDULE 13G/A Lexeo Therapeutics, Inc. Filed by: Longitude Capital Partners IV, LLC
Medium Report
Form SCHEDULE 13G/A Lexeo Therapeutics, Inc. Filed by: Longitude Capital Partners IV, LLC
Report
11/14
04:01 pm
lxeo
Form SCHEDULE 13G/A Lexeo Therapeutics, Inc. Filed by: Vestal Point Capital, LP
Medium Report
Form SCHEDULE 13G/A Lexeo Therapeutics, Inc. Filed by: Vestal Point Capital, LP
Report
11/14
12:49 pm
lxeo
Form SCHEDULE 13G/A Lexeo Therapeutics, Inc. Filed by: JANUS HENDERSON GROUP PLC
Low Report
Form SCHEDULE 13G/A Lexeo Therapeutics, Inc. Filed by: JANUS HENDERSON GROUP PLC
Report
11/14
06:10 am
lxeo
Form SCHEDULE 13G/A Lexeo Therapeutics, Inc. Filed by: BALYASNY ASSET MANAGEMENT L.P.
Low Report
Form SCHEDULE 13G/A Lexeo Therapeutics, Inc. Filed by: BALYASNY ASSET MANAGEMENT L.P.
Report
11/7
04:42 pm
lxeo
Form SCHEDULE 13G/A Lexeo Therapeutics, Inc. Filed by: INTEGRATED CORE STRATEGIES (US) LLC
Medium Report
Form SCHEDULE 13G/A Lexeo Therapeutics, Inc. Filed by: INTEGRATED CORE STRATEGIES (US) LLC
Report
11/5
09:02 am
lxeo
Form S-3 Lexeo Therapeutics, Inc.
Medium Report
Form S-3 Lexeo Therapeutics, Inc.
Report
11/5
07:56 am
lxeo
Form S-8 Lexeo Therapeutics, Inc.
Medium Report
Form S-8 Lexeo Therapeutics, Inc.
Report
11/5
07:41 am
lxeo
Form 10-Q Lexeo Therapeutics, Inc. For: Sep 30
Medium Report
Form 10-Q Lexeo Therapeutics, Inc. For: Sep 30
Report
11/5
07:39 am
lxeo
Form 8-K Lexeo Therapeutics, Inc. For: Nov 05
Medium Report
Form 8-K Lexeo Therapeutics, Inc. For: Nov 05
Report
10/27
04:07 pm
lxeo
Form SCHEDULE 13G Lexeo Therapeutics, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
Low Report
Form SCHEDULE 13G Lexeo Therapeutics, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
Report
10/17
07:30 pm
lxeo
Form 4 Lexeo Therapeutics, Inc. For: Oct 15 Filed by: See Tai Sandi
Medium Report
Form 4 Lexeo Therapeutics, Inc. For: Oct 15 Filed by: See Tai Sandi
Report
10/17
07:29 pm
lxeo
Form 4 Lexeo Therapeutics, Inc. For: Oct 15 Filed by: Robertson Jenny
Medium Report
Form 4 Lexeo Therapeutics, Inc. For: Oct 15 Filed by: Robertson Jenny
Report
Latest Posts

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview
Earnings Week Wrap-up and Takeaways
Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix
Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More
The Smart Way to Ten Minutes Per Day
Information

Information

Support

Support

Contact us

Contact us

11201 N Tatum Blvd
Suite 300-79795
Phoenix, AZ 85028
info@newsquantified.com

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview
Earnings Week Wrap-up and Takeaways
Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix
Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More
The Smart Way to Ten Minutes Per Day

Information

Support

Contact us

11201 N Tatum Blvd
Suite 300-79795
Phoenix, AZ 85028
info@newsquantified.com
Stay in the know news, product updates and promotions.
Copyright Ⓒ News Quanitifed LLC 2012-2025, All product trademarks, names, logos, and brands are property of their respective owners. Image(s) or Footage (as applicable), used under license from Shutterstock.com. 3.0.0